Massive empyema caused by Mycoplasma pneumoniae in an adult: a case report

Mony Shuvy1, Moshe Rav-Acha, Uzi Izhar

  • 1Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. shuvi@bgumail.bgu.ac.il

BMC Infectious Diseases
|February 3, 2006
PubMed
Abstract

Insights

Mycoplasma pneumoniae rarely causes empyema in adults. This case highlights its underdiagnosis in older patients due to unreliable serology, suggesting PCR is crucial for identifying this severe pleural complication.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Microbiology

Background:

  • Mycoplasma pneumoniae causes significant community-acquired pneumonia and upper respiratory illnesses.
  • While CNS and pericardial involvement are known complications, severe pleural disease is rarely reported.
  • Underdiagnosis stems from limited culture methods and underappreciation of invasive potential.

Observation:

  • A 57-year-old woman presented with massive pleural effusion, leukocytosis, and elevated ESR.
  • Initial microbiological tests on pleural fluid were negative before antibiotic treatment.
  • Polymerase Chain Reaction (PCR) detected Mycoplasma pneumoniae DNA in the empyema fluid.

Findings:

  • This is the first reported case of Mycoplasma pneumoniae-related empyema in an adult.
  • Serological testing was indeterminate (titer 1:80), proving unhelpful for diagnosis in this older patient.
  • PCR confirmed Mycoplasma pneumoniae as the causative agent, despite negative initial cultures.

Implications:

  • Mycoplasma pneumoniae empyema may be an underdiagnosed complication, particularly in adults.
  • Serological insensitivity in older individuals necessitates alternative diagnostic methods like PCR.
  • Early and accurate diagnosis is vital for effective treatment of severe M. pneumoniae infections.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.